Healthcare
Live Price
Offline$0.149
+0.00% today
1Y Change
-48.26%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
BioPorto A/S (THOXF) is a Healthcare stock with a market cap of $600.00M and listed on OTC. The stock last traded around $0.15 and down 48.3% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +10.9%, EPS growth of +11.8%, a dividend yield of 0.0%. What stands out right now is revenue +10.9%, EPS +11.8%, free cash flow +8.4% with operating margin -213.7% and ROIC -114.4%. Valuation already assumes a fairly strong business story at price/sales 14.8. Stock Foundry combines THOXF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
THOXF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
THOXF Max Drawdown
-48.26%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for THOXF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$24.3M
-16.3% YoY
FY Net Income
-$57.1M
+24.8% YoY
Free Cash Flow
-$65.0M
-22.7% YoY
Revenue Growth
+10.9%
EPS Growth
+11.8%
Gross Margin
75.4%
Net Margin
-203.8%
Income statement
DKK
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 40M | 36M | 31M | 29M | 24M |
| Gross Profit | 28M | 25M | 20M | 19M | 15M |
| Operating Income | -86M | -75M | -61M | -79M | -65M |
| EBITDA | -83M | -71M | -58M | -76M | -59M |
| Net Income | -82M | -68M | -56M | -76M | -57M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
DKK
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 55M | 60M | 66M | 82M | 46M |
| Total Assets | 93M | 96M | 90M | 109M | 81M |
| Total Liabilities | 30M | 28M | 30M | 38M | 35M |
| Shareholder Equity | 63M | 68M | 60M | 70M | 46M |
| Total Debt | 8M | 11M | 7M | 11M | 13M |
| Net Debt | -47M | -48M | -59M | -71M | -32M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
65M
-23.0% YoY
Capital Expenditures
389K
+17.4% YoY
Free Cash Flow
65M
-22.7% YoY
Key ratios
Gross Margin
75.4%
Operating Margin
-213.7%
Net Margin
-203.8%
ROE
-166.9%
Debt / Equity
0.12x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.